Conclusion: "Leronlimab resulted in significantly
Post# of 151802

"Leronlimab resulted in significantly reduced plasma HIV-1 within one week after addition to failing ART. After 24 weeks combined with an OBT, most participants had plasma HIV-1 RNA levels <50 copies per mL plasma, suggesting utility of leronlimab as a component of salvage therapy."
Chatbot Ai interpretation:
This statement indicates that after a treatment period of 24 weeks, during which participants received both a specific therapy (referred to as "OBT," which typically means "optimized background therapy"


